Abstract:OBJECTIVE:To investigate the expression of fascin and cytokeratin 14 (CK14) in human esophageal squamous cell carcinoma (ESCC) and the association of these two proteins with ESCC malignant progression and the possibility of application of these 2 proteins in the diagnosis of ESCC.METHODS:A tissue microarray composed of the representative regions of ESCC and corresponding normal epithelium was constructed. Immunohistochemistry was conducted to examine the expression of fascin and CD14 in 116 specimens of ESCC and the normal tissues near the cancerous tissues. The relation of these two proteins with the invasive depth, node involvement, differentiated grade, pTNM stages was analyzed. Disease-free survival analysis was carried out using Kaplan-Meier method. The correlation of the two proteins was analyzed using Spearman's correlation test. ESCC cells of the lines EC9706, TE12, COLO-680N, KYSE510, KYSE450, KYSE410, KYSE180, KYSE150, KYSE140, KYSE70, KYSE30, and YES2 were cultured and underwent SDS-PAGE and Western blotting to examine the expression of fascin and CD14. And the correlation of the two proteins with the characteristics of the cell lines was analyzed too.RESULTS:Fascin and CK14 were negative in the normal esophageal epithelia except in the basal cells. The positive rates of fascin and CK14 in the ESCC cells were 79.3% and 67.0% respectively. The positive rate of either fascin or CK14 was 86.2%. The expression rates of fascin and CK14 in well- and moderately-differentiated ESCCs were significantly higher than that in the poorly-differentiated ones (P = 0.054 and P < 0.01). The patients with positive expression of fascin and those with negative expression of CK14 had a poorer survival in comparison with those with negative fascin expression and those with positive CK14 expression respectively, however, without statistical significances (P = 0.8980 and P = 0.2610). The positive rates of fascin in the well-, moderately-, and poorly- differentiated ESCCs were 87.1%, 83.9%, and 62.1% respectively (P = 0.054). The positive rates of CK14 in the well-, moderately-, and poorly-differentiated ESCCs were; 87.1%, 76.4%, and 27.6% respectively (P < 0.01). The prognosis was not significantly correlated with the expression of both proteins (P = 0.8980 and P = 0.2610). There was an significantly positive correlation between the expression levels of these 2 proteins (r = 0.487, P < 0.01). Fascin was highly expressed in most of the ESCC lines, except in the slowly growing and weakly migrating TE12 line. High expression of CK14 was only seen in the line KYSE180.CONCLUSION:Fascin and CK14 may play important roles in the carcinogenesis and progression of ESCC. Combination of fascin and CK14 would be valuable markers in diagnosis of ESCC.

Expressions of a Disintegrin and Metalloprotease 17 and Epidermal Growth Factor Recepter in Esophageal Squamous Cell Carcinoma and Their Significances

[Expression of Fas, Fas Ligand, Fas-associated Death Domain Protein, Caspase 8 and Mutant P53 Protein in Esophageal Squamous Cell Carcinoma].

[Expression of Fascin and Cytokeratin 14 in Esophageal Squamous Cell Carcinoma].

A Disintegrin and Metalloproteinase 17 Mrna and Protein Expression in Esophageal Squamous Cell Carcinoma, As Well As Its Clinicopathological Factors and Prognosis

Expression of P-EGFR and P-Akt Protein in Esophageal Squamous Cell Carcinoma and Its Prognosis

Expressions of p-EGFR and p-Akt proteins in esophageal squamous cell carcinoma tissue

Expressions of EGFR and PTEN in Esophageal Carcinoma Tissues

Protein Overexpression and Gene Amplification of EGFR in Esophageal Squamous Cell Carcinoma: Relationship Between Malignant Biologic Behavior and EGFR Status Study.

Expression and Clinical Significance of A Disintegrin and Metalloprotease 8 (ADAM8) and Epidermal Growth Factor Receptor (EGFR) in Non-small Cell Lung Cancer

Abnormal P16 Expression and Prognostic Significance in Esophageal Squamous Cell Carcinoma.

Expression of EGFR,GST-π and C-erbB-2 in esophageal squamous cell carcinoma and their clinical significance

Clinical significance of EGFR and EGFRvIII expression in human esophageal carcinoma

Correlation of epidermal growth factor receptor overexpression with increased epidermal growth factor receptor gene copy number in esophageal squamous cell carcinomas.

Expression of PC Cell-Derived Growth Factor and Vascular Endothelial Growth Factor in Esophageal Squamous Cell Carcinoma and Their Clinicopathologic Significance.

The Prognostic Value of EGFR Overexpression and Amplification in Esophageal Squamous Cell Carcinoma

The Expression and Correlation of HIF-1α,VEGF And EGFR Protein in Tissues Esophageal Squamous Cell Carcinoma

Clinical significance of the expression of EGFR signaling pathway-related proteins in esophageal squamous cell carcinoma

Epidermal Growth Factor Receptor Protein Overexpression and Gene Amplification Are Associated with Aggressive Biological Behaviors of Esophageal Squamous Cell Carcinoma.

Expression of Nucleostemin, epidermal growth factor and epidermal growth factor receptor in human esophageal squamous cell carcinoma tissues

Expression and Significance of Epidermal Growth Factor Receptor Variant Ⅲ and Matrix Metalloproteinase-2 in Human Esophageal Carcinoma

The significance of PDGFRαand PDGFRβin esophageal squamous cell carcinoma expression and clinical pathology